Twist1 Regulates Vimentin through Cul2 Circular RNA to Promote EMT in Hepatocellular Carcinoma
Top Cited Papers
Open Access
- 31 July 2018
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 78 (15), 4150-4162
- https://doi.org/10.1158/0008-5472.can-17-3009
Abstract
Twist is a critical epithelial–mesenchymal transition (EMT)–inducing transcription factor that increases expression of vimentin. How Twist1 regulates this expression remains unclear. Here, we report that Twist1 regulates Cullin2 (Cul2) circular RNA to increase expression of vimentin in EMT. Twist1 bound the Cul2 promoter to activate its transcription and to selectively promote expression of Cul2 circular RNA (circ-10720), but not mRNA. circ-10720 positively correlated with Twist1, tumor malignance, and poor prognosis in hepatocellular carcinoma (HCC). Twist1 promoted vimentin expression by increasing levels of circ-10720, which can absorb miRNAs that target vimentin. circ-10720 knockdown counteracted the tumor-promoting activity of Twist1 in vitro and in patient-derived xenograft and diethylnitrosamine-induced TetOn-Twist1 transgenic mouse HCC models. These data unveil a mechanism by which Twist1 regulates vimentin during EMT. They also provide potential therapeutic targets for HCC treatment and provide new insight for circular RNA (circRNA)-based diagnostic and therapeutic strategies. Significance: A circRNA-based mechanism drives Twist1-mediated regulation of vimentin during EMT and provides potential therapeutic targets for treatment of HCC. Graphical Abstract: http://cancerres.aacrjournals.org/content/canres/78/15/4150/F1.large.jpg. Cancer Res; 78(15); 4150–62. ©2018 AACR.Keywords
Other Versions
Funding Information
- National Natural Science Foundation of China (81572838, 81402973, 81703581)
- Natural Science Foundation of Tianjin City (15JCYBJC26400)
- National Science and Technology Major Project (2017ZX09306007)
- Tianjin Science and Technology Project (15PTGCCX00140)
This publication has 37 references indexed in Scilit:
- The Role of Vimentin Intermediate Filaments in the Progression of Lung CancerAmerican Journal of Respiratory Cell and Molecular Biology, 2014
- Regulatory networks defining EMT during cancer initiation and progressionNature Reviews Cancer, 2013
- Foxa1 and Foxa2 Are Essential for Sexual Dimorphism in Liver CancerCell, 2012
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: A study of hepatocellular carcinomaHepatology, 2011
- Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transitionThe FASEB Journal, 2010
- Introducing intermediate filaments: from discovery to diseaseJCI Insight, 2009
- The transcriptional repressor ZBP-89 and the lack of Sp1/Sp3, c-Jun and Stat3 are important for the down-regulation of the vimentin gene during C2C12 myogenesisDifferentiation, 2009
- CUL2 Is Required for the Activity of Hypoxia-inducible Factor and VasculogenesisPublished by Elsevier BV ,2008
- Function and regulation of cullin–RING ubiquitin ligasesNature Reviews Molecular Cell Biology, 2005